|1.||Sankaranarayanan, Ananthakrishnan: 1 article (01/2007)|
|2.||Sabatier, Jean-Marc: 1 article (01/2007)|
|3.||Shakkottai, Vikram: 1 article (01/2007)|
|4.||Kolski-Andreaco, Aaron: 1 article (01/2007)|
|5.||Wulff, Heike: 1 article (01/2007)|
|6.||Wirtz, Stephan: 1 article (10/2004)|
|7.||Schuhmacher, Joachim: 1 article (10/2004)|
|8.||Hinz, Volker: 1 article (10/2004)|
|9.||Horváth, Ervin: 1 article (10/2004)|
|10.||Hofmann, Heiko A: 1 article (10/2004)|
|1.||Brain Injuries (Brain Injury)
10/01/2004 - "In the rat acute subdural haematoma model, both the triazole and cyclohexadiene displayed reduction of brain water content (-26% at 0.3 mg/kg and -24% at 0.01 mg/kg) and reduction of the intracranial pressure (-46% at 0.1 mg/kg and -60% at 0.003 mg/kg) after 24 h when administered as a 4-h infusion immediately after brain injury. "
01/01/2007 - "Experiments showing that a cyclohexadiene KCa3.1 blocker reduces infarct volume in a rat subdural hematoma model further suggest KCa3.1 as a target for the treatment of traumatic and possibly ischemic brain injury. "
|2.||Endometrial Neoplasms (Endometrial Cancer)
07/01/1983 - "These tumors were minimally responsive to the 2,5-bis(1-aziridinyl-3,6-dioxodiethyl ester of 1,4-cyclohexadiene-1,4-dicarbamic acid (NSC 182986) and cis-diamminedichloroplatinum II and unresponsive to methotrexate, 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido(2,3-d)pyrimidine (NSC 351521), 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC 409962), and procarbazine. "
|4.||Hepatocellular Carcinoma (Hepatoma)
|5.||Subdural Hematoma (Subdural Hemorrhage)